Three phase 3 prostate cancer results from ESMO 2026 cover long-term survival with abiraterone in metastatic disease, Erleada before and after surgery, and an update on Truqap for PTEN-deficient ...

Rodger Allen has been training in sand dunes to prepare for his desert challenge.

Researchers at Endeavor Health and GoPath Diagnostics have developed a new genetic test that can help predict which men with prostate cancer are most likely to develop aggressive, life-threatening ...

The Decipher genomic test could help doctors decide which high-risk prostate cancer patients need abiraterone hormone therapy ...

An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...

November is a great month where men's health awareness is brought to a forefront and it's a really important opportunity because, quite honestly, men don't do as well as women when it comes to seeing ...

Johnson & Johnson (J&J) said that an early-stage trial of JNJ-6143 (previously HLD-0915) found that the novel oral Regulated ...

Prostate-specific membrane antigen (PSMA)-targeted radiopharmaceutical therapy is safe and effective for patients with ...

The prostate is a walnut-sized organ that sits behind your penis. Its purpose is to help make semen. It usually gets larger with age. Sometimes as the prostate gets larger with age, cancer cells form ...

The FDA has expanded its approval of talazoparib in combination with enzalutamide to include men with metastatic androgen ...

Recent study links blood proteins to aggressive prostate cancer, identifying potential biomarkers for early risk prediction ...

Women can get cancer in the Skene’s glands, sometimes called the “female prostate.” Skene’s gland cancer is very rare, with only about 20 reported cases to date. Treatment for Skene’s gland cancer may ...